Presented By:
Michael De La Cruz, Ph.D.
Tom Fletcher
Speaker Biography:
Michael De La Cruz is a Senior Scientist at FUJIFILM Irvine Scientific in the newly formed group supporting the Manufacturing Sciences and Technology service. As part of the Process Sciences organization, Mike will help users simplify their cell culture media process workflows by analyzing and improving media and buffer preparation. With over 20 years of experience in the biopharmaceutical industry, he has both a breadth and depth of experiences including translational research, process development, and manufacturing. He holds a Ph.D. in Applied Life Sciences from the Keck Graduate Institute, and his professional experiences at Regeneron, Genentech, Amgen, and City of Hope have given him a unique perspective and expertise in media and protein production.
Thomas Fletcher is Director of Process Development R&D, at FUJIFILM Irvine Scientific, a company that specializes in the development, manufacture, and supply of cell culture media for a variety of applications. As a part of the Industrial Cell Culture business, Thomas leads the company’s efforts to provide relevant solutions for the various and frequent challenges presented by upstream process development. He has over 30 years of experience serving the biopharmaceutical industry, mostly by developing cell culture media for large-scale production processes. Thomas has previous experience in protein chemistry research at the University of California, Irvine School of Medicine and working at Becton Dickinson & Co.
Webinar:
Delivering Improved Bioprocessing Workflows: The Manufacturing Science and Technology (MSAT) Service
Webinar Abstract:
Join us as we discuss the new Manufacturing Science and Technology (MSAT) Service offering, created in response to the needs of biopharmaceutical manufacturers for better cell culture media and buffer preparation methods. The MSAT Service focuses on developing user-friendly cell culture media for late-stage development and manufacturing of biologic drug substances and cell and gene therapies when priorities shift from process performance to improving efficiencies and reducing risks. Whether the needs are to reduce cost, save time, improve reliability, or all of the above, the MSAT Service helps identify opportunities for practical improvement of existing solution preparation processes. The MSAT service will provide support and targeted solutions to manufacturers, focusing on simplifying media preparation methods, improving the solubility of powder media, characterizing and troubleshooting the drug substance bill of materials, and introducing new technologies. Case studies will be provided as examples of targeted approaches toward simplifying complex media and buffer preparation methods to more user-friendly and robust methods.
LabRoots on Social:
Facebook: / labrootsinc
Twitter: / labroots
LinkedIn: / labroots
Instagram: / labrootsinc
Pinterest: / labroots
SnapChat: labroots_inc
21 июн 2022
